Specifically, Li L. et al. demonstrated in their study that AI counting for Ki-67 is highly consistent with the gold standard, meeting and even surpassing the International Breast Cancer Working Group’s recommended cell number range [39]. This evidence concerns the gene MKI67 and breast carcinoma.